UNSPSC 51284020: Chlortetracycline hydrochloride

This classification denotes a tetracycline antibiotic with the molecular formula C22H23ClN2O8.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O1GX33ON8R, chemically known as 2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione but more generally known as chlortetracycline hydrochloride, which bears US NIH Compound Identifier 5280963.

UNSPSC 51284020 Chlortetracycline hydrochloride is a Commodity code capturing pharmaceutical products procured by state and local health agencies, though the recent activity tagged to this code shows limited direct relevance. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for supply of Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets across 12 months with two renewal options; that procurement used an Invitation for Bid process and does not align with the chlortetracycline hydrochloride commodity name. Separately, Seminole County, Florida released an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for quarterly delivery to the Seminole County Community Health Building, also unrelated to chlortetracycline hydrochloride. State and local health departments and counties appear to be the primary issuing bodies under pharmaceutical procurement vehicles, though the opportunities recorded against this code reflect broader pharmaceutical product sourcing rather than chlortetracycline specifically.

The code shows activity in Florida and Illinois with pharmaceutical procurement spanning health department and county community health settings. The Illinois opportunity demonstrates use of cooperative purchasing through MMCAP Infuse for warehouse pharmaceutical sourcing, while the Seminole County opportunity signals municipal health system procurement of emergency and public health supplies. Recent solicitations show response deadlines clustered in the summer of 2026, with contracts structured around annual terms with renewal options and requirements for electronic submission, insurance compliance, and drug-free workplace certification. The source does not support identifying chlortetracycline hydrochloride as a stand-alone or frequently solicited product; the code appears to capture specialty pharmaceuticals bought in lower volume or bundled within broader health-supply procurement vehicles.